Connect with us

Health & Fitness

Kasapreko Company Limited Halts The Production of Drinks To Produce Hand Sanitizers To Support Ghana’s Fight Against Corona Virus.

Published

on

Kasapreko Company Limited, an Indigenous Manufacturing giant and (ISO) Certified company, has responded positively to the request of H.E. President Nana Addo Danquah Akufo Addo’s appeal for local Industries to produce hand sanitizers to curb the spread of Coronavirus disease in Ghana.

At a groundbreaking production and media briefing, the Chief Executive Officer of Kasapreko Company Limited, Mr Richard Adjei Said: “The spread of Coronavirus is a national concern and as a result, we have put on hold the production of drinks and focused on the production of quality, affordable Hand Sanitizers and Hand Rubbing Alcohol amid a shortage of these products and price hikes.”

Mr Adjei reiterated H.E. President Nana Addo Danquah Akufo Addo’s quote “these are not ordinary times”; in which we need to do everything possible to support the government’s efforts in smart ways to help prevent the viral outbreak.

Commenting further on the new product, Mr Adjei commended the Research and Development Unit of Kasapreko and the Food and Drugs Authority for responding quickly to the challenge and hence the approval of the production of Kasapreko Hand Sanitizers and Hand Rubbing Alcohol. He went on further to say that the production capacity can produce over 200,000 bottles a day.
Kasapreko Hand Sanitizer and Rubbing Alcohol contain active ingredients such as Ethanol, Hydrogen Peroxide, Glycerin and Purified Water. This type is without gelling agent, fragrance or colour as recommended by the World Health Organization.

The Hand Sanitizer and Hand Rubbing Alcohol comes in various sizes, 750 ml and 200 ml bottle. It is made in a way that you can easily dispense into any container with the spray pump.

Concluding, He assured the government and the general public of the product’s availability across the country and pledge to donate free quantities to various Health and governmental agencies.

Meanwhile, the company advised the general public to keep to the standard protocols from the World Health Organization and the Ghana Health Service.
• Avoid Hand Shaking and Hugging.
• Wash your hands frequently with soap under running water.
• Practice Social Distancing.
• Don’t touch your face, eyes, mouth or nose with unwashed hands.

If you are coughing, feeling feverish or having difficulty in breathing report to the nearest Hospital. Follow the Hygienic and Safety precautions and Stay Alive and Healthy.

Health & Fitness

Russia Completes Human Trials Of COV¡D-19 Vaccine

Published

on

After Brazil was the first emerging market to get a test drive of the Oxford University coronavirus vaccine, it’s Russia that is the first to complete human trials.

Elena Smolyarchuk, chief researcher for the Russian Center for Clinical Research on Medications at Sechenov University, told TASS newswire on Sunday that human trials for the vaccine had been completed and those test patients will be discharged soon.

“The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20,” Smolyarchuk was quoted as saying in the report.

There was no other information on when this vaccine would enter commercial production.

Russia had allowed clinical trials of two forms of a potential coronavirus vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology. The first one was carried out at the Burdenko Military Hospital. The other vaccine was given to test patients at the Sechenov First Moscow State Medical University.

After being given the shot, the volunteers were asked to quarantine in the hospital for 28 days.

Earlier, results of the Covid-19 vaccine tests performed on a group of volunteers in Russia showed that they were developing immunity to the coronavirus, but what the drug actually is was not discussed in the article.

Russia has reported 719,449 cases of the new SARS coronavirus. Some 11,188 people have died from complications caused by Covid-19, the disease caused by the new SARS.

There are at least 21 vaccines currently under trial worldwide, according to the World Health Organisation. Every country and every lab is taking a different approach to finding the right solution to stop the virus from taking over the world at this point.

Meanwhile, in Moscow this weekend, public health officials lifted the requirements of wearing face masks while outside. Masks and gloves are mandatory when riding public transportation, going to a medical center, or while shopping.

– Forbes.com

Continue Reading

Health & Fitness

WHO Update Its Guidance On Who Should Wear A Mask And When It Should Be Worn – [WATCH]

Published

on

Since the outbreak of the deadly Coronavirus which has swept through the world, the World Health Organization has been providing various guidance to protect the general public.

In the latest video shared by Director-General of the World Health Organization, Tedros Adhanom, the World Health Organization provided an update on the safety guidance based on research carried out by the organization.

The guidance covers who is supposed to wear the masks, when it’s compulsory to wear the mask and lastly what the mask should be made of in terms of layers of fabrics. Most of the guidance encourages people to wear the mask in areas identified to be a hot zone for the rise of COVID-19.


Watch the full video below:

Continue Reading

Health & Fitness

2,000 Participants To Be Entered Into South Africa’s First Covid-19 Vaccine Trial

Published

on

South Africa is very much in the early phase of the pandemic, says expert.

South Africa’s University of the Witwatersrand (Wits) announced on Tuesday during a virtual press conference that it will begin the continent’s first clinical trial for a Covid-19 vaccine. Leading the South African Ox1Cov-19 Vaccine VIDA-Trial is Shabir Madhi, Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (VIDA).

“This is a landmark moment for South Africa and Africa at this stage of the Covid-19 pandemic. As we enter winter in South Africa and pressure increases on public hospitals, now more than ever, we need a vaccine to prevent infection by Covid-19,” said Madhi at the launch.

“We began screening participants for the South African Oxford 1 Covid-19 vaccine trial last week and the first participants will be vaccinated this week,” he added.

Speaking to FORBES AFRICA, Martin Veller, Dean of the Faculty of Health Sciences at Wits, believes South Africa is very much in the early phase of the pandemic.

“We will be seeing a lot more cases. And that is already reflected in the significant increase of the numbers that we’ve seen in the country.”

South Africa’s total number of cases has surpassed 100,000 with the death toll reaching 1,991.

The South African Ox1Cov-19 Vaccine VIDA-Trial will start tomorrow, June 24.

“2,000 people will be entered into the trial. It’s important to note that the trial is largely going to be a placebo-controlled trial. One needs to see firstly what the safety of the vaccine is but much more importantly whether it’s effective,” says Veller.

He further stated that the participants will be followed for a whole year and the results will be analysed intermittently.

The institution is also collaborating with other institutions on the vaccine trial.

“Because of the expertise that Professor Madhi, his colleagues at Oxford University very early on contacted him to take part in the development and the trials of this vaccine,” says Veller.

Wits will also be collaborating with the Jenner Institute at Oxford University on the trial.

– Forbes Africa

Continue Reading

Health & Fitness

Mr. Maxwell Dodd Launches Sickle Cell Anaemia Relief International To Support Carriers

Published

on

In commemoration of the World Sickle Cell Day, The Executive Director, Mr Maxwell Dodd has, on Friday June 19, 2020, virtually launched the Sickle Cell Anaemia Relief International (SCAR) that is essential to tell the real and personal life stories, shed light on the challenges faced by carriers and support them financially.

Through this project, SCAR will make society better for all Sickle Cell carriers whiles putting eternal smiles on their faces. The theme for this year’s Celebration is “Shine the light on Sickle Cell” which primarily is to create more societal awareness on this Public Health Disease and the challenges the carriers, family and care givers face.

World Sickle Cell Day was established by the United Nation’s General Assembly in 2008 in order to increase the awareness about the sickle cell diseases and its cure among the general public. It was first celebrated on 19th June, 2009. This year, the date has been chosen to commemorate the day on which a resolution was officially adopted by the United Nation’s General Assembly, significantly recognizing Sickle Cell Disease(SCD) as a Public Health Concern.

According to the World Health Organization, SCD which affects over millions of people worldwide including adults and children, is one of the main cause of premature death among children under the age of five in various African countries. SCD is a potentially fatal disease.

Continue Reading

Trending

Copyright © 2019-2020 GBAfrica.net